Acromegaly: Long-term overuse can lead to abnormal growth of bones and tissues
Triple GLP- 1/GIP/Glucagon Receptor Agonists- Retatrutide Retatrutide is being developed as a once-weekly subcutaneous injection of a triple GLP- 1, GIP, and glucagon receptor agonist to treat T2DM [109]
While peptides like BPC-157, IGF-1 LR3, Ipamorelin, and HCG are not commonly included in routine drug tests, they are detectable under specialized conditions especially in elite sport testing
Joseph KS, Kinniburgh B, Metcalfe A, et al
A full 1-litre infusion runs for around 45 minutes
Laboratory research record on GLP-1S [PMID: 35175229] PubMed laboratory record discussing GLP-1S in a research context